China green lights coronavirus vaccine candidate for use on its military.

WATCH: Canadian trials set to begin in race to develop a COVID-19 vaccine

China’s military has received the greenlight to use a COVID-19 vaccine candidate developed by its research unit and CanSino Biologics after clinical trials proved it was safe and showed some efficacy, the company said on Monday.

The Ad5-nCoV is one of China’s eight vaccine candidates approved for human trials at home and abroad for the respiratory disease caused by the new coronavirus. The shot also won approval for human testing in Canada.

China’s Central Military Commission approved the use of the vaccine by the military on June 25 for a period of one year, CanSino said in a filing. The vaccine candidate was developed jointly by CanSino and a research institute at the Academy of Military Science (AMS).

“The Ad5-nCoV is currently limited to military use only and its use cannot be expanded to a broader vaccination range without the approval of the Logistics Support Department,” CanSino said, referring to the Central Military Commission department which approved the military use of the vaccine.

Trending Stories

  • These Canadians say they suffered COVID-19 symptoms for months

  • For 3rd day in a row, U.S. coronavirus cases surge by more than 40,000

CanSino declined to disclose whether the innoculation of the vaccine candidate is mandatory or optional, citing commercial secrets, in an email to Reuters.

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

The military approval follows China’s decision earlier this month to offer two other vaccine candidates to employees at state-owned firms travelling overseas.

The Phase 1 and 2 clinical trials of the CanSino’s vaccine candidate showed it has the potential to prevent diseases caused by the coronavirus, which has killed half a million people globally, but its commercial success cannot be guaranteed, the company said.

Separately, AMS received an approval earlier this month to test its second experimental coronavirus vaccine in humans.

No vaccine has yet been approved for commercial use against the illness caused by the new coronavirus, but over a dozen vaccines from more than 100 candidates globally are being tested in humans.

View link »

© 2020 Reuters

Related news

Hefty Prison Terms Sought For 'New Greatness' Youth Activists.

A Russian prosecutor has demanded that three members of the New Greatness youth activist group facing extremism charges receive between four and 7.5 years in prison.

No Vaccine, No Carnival, Warn Rio's Samba Schools Amid Coronavirus Crisis.

Some of Rio's biggest samba schools say they will not participate in next year's Carnival unless a coronavirus vaccine is widely available, Brazilian media reported Tuesday.

Navalny Summoned For Questioning In Libel Case

Russian opposition politician Aleksei Navalny has been summoned for questioning in a criminal case launched over comments he made on social media.

Jeffrey Epstein's Girlfriend Denies Charges Of Sex Trafficking In US.

British socialite Ghislaine Maxwell pleaded not guilty in a New York court Tuesday to sex trafficking minors for her former partner, the late financier Jeffrey Epstein.

Reuters: EU removes Serbia, Montenegro from coronavirus safe list.

The updated list will be published in coming hours or days.

By continuing to browse World News (UAZMI), you acknowledge that you have read the Terms of Use and agree to the use of cookies